🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to determine whether a fixed dose combination...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-11-30
Trial ID
NCT02233543
Treatments Being Tested
This will be a phase IV, open label, multicenter, randomized pragmatic stud...
Status
Terminated
Location
Istituti Clinici Scientifici Maugeri, Pneumologia Riabilitativa
Start Date
2018-11-11
Trial ID
NCT03662711
Treatments Being Tested
This is a formulation feasibility study to to compare relative bioavailabil...
Status
Completed
Location
CRST Helsinki Oy
Start Date
2022-02-28
Trial ID
NCT05288075
Treatments Being Tested
This study is designed to directly compare the effects of widely available ...
Status
Suspended
Location
II Department of Lung Diseases, Lung Cancer and Internal Diseases
Start Date
2024-03-11
Trial ID
NCT07541378
Treatments Being Tested
The aim of the present study is to evaluate the superiority of the fixed tr...
Status
Completed
Location
Chiesi Farmaceutici S.p.A.
Start Date
2015-05-29
Trial ID
NCT02579850
For effective drug delivery using inhalation route, it is important to use ...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-06-08
Trial ID
NCT03114969
The objective of this study is to assess pharmacokinetics (PK) of indacater...
Status
Completed
Location
CRST Helsinki Oy
Start Date
2021-05-07
Trial ID
NCT04856098
To evaluate the efficacy and safety of HL231 Solution for Inhalation vs Ult...
Status
Completed
Location
West China Hospital of Sichuan University
Start Date
2022-01-12
Trial ID
NCT06619210
Treatments Being Tested
This study was evaluating the effect of reminder notifications and motivati...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2018-07-11
Trial ID
NCT03379233
Treatments Being Tested
Rationale: Inhaled bronchodilators, beta-2-agonist or anticholinergic or c...
Status
Completed
Location
UMCG
Start Date
2015-12
Trial ID
NCT02576626